Records containing: Maple Syrup Urine Disease

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-19
A Study To Evaluate The Acceptability Of the Express Plus Range, Foods For Special Medical Purposes (FSMP), In Children And Adults With Inborn Errors of Metabolism (IEM)
CLINICAL_TRIALS study record update · 2025-08-12
Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
CLINICAL_TRIALS study record update · 2024-10-30
MyRareDiet™: A Diet Tracking, Monitoring and Optimization mHealth Tool for Patients With Inborn Errors of Metabolism
CLINICAL_TRIALS study record update · 2024-09-03
Valine 50mg/ml and Isoleucine 25mg/ml Oral Solutions for Maple Syrup Urine Disease (MSUD) - Acceptability and Tolerance Study
CLINICAL_TRIALS study record update · 2024-06-04
Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-02-07
Systemic Biomarkers of Brain Injury From Hyperammonemia
CLINICAL_TRIALS study record update · 2023-06-18
Introduction of Tandem Mass Spectrometry (MS/MS) Technology in the Program of Selective Screening of Hereditary Metabolic Diseases in Kazakhstan
CLINICAL_TRIALS study record update · 2020-11-04
Identification and Validation of Relevant Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
CLINICAL_TRIALS study record update · 2019-03-06
A Double-Blind, Randomized, Placebo-Controlled, Crossover Trial of Phenylbutyrate in the Treatment of Maple Syrup Urine Disease